NCT01347112View on ClinicalTrials.gov

Varenicline Treatment for Active Alcoholic Smokers

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

March 31, 2014

Conditions

SmokingTobacco DependenceAlcohol Dependence

Interventions

DRUG

Varenicline

varenicline 1.0 mg dose, twice daily for 12 weeks

DRUG

placebo

sugar pill twice daily for 12 weeks

Trial Locations (2)

54601

Franciscan Skemp Hospital, La Crosse

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER